Tentt

Servier to Take Day One Biopharmaceuticals Private

Announced
HealthcareGoing Private

Deal Overview

Servier Detroit Inc., a direct wholly owned subsidiary of Servier Pharmaceuticals LLC, filed Amendment No. 2 to its Schedule TO under Rule 13e-3 for a going-private tender offer for Day One Biopharmaceuticals, Inc. The filing relates to an offer by the Servier Parties to purchase all issued and outstanding shares of Day One common stock.

The Schedule TO amendment was filed on top of the original tender offer statement submitted March 26, 2026, and it updates Item 11 Additional Information, including an amended and restated Antitrust Compliance section. The filing references the Offer to Purchase and related tender documents as exhibits.

Key Details

Transaction
Servier Detroit acquires Day One Biopharmaceuticals

Filed under

Source

Read full article on sec.gov

via SEC EDGAR — SC TO · April 8, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →